COVID-19 Advocacy: Working with the Federal Agencies
Join us for a discussion of ASHP’s advocacy engagement with FDA, DEA, and CMS to address shortages and create regulatory flexibility to allow for an effective COVID-19 response.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"ASHPOfficial","authorlink":""},"src":"https:\/\/chtbl.com\/track\/383G87\/mcdn.podbean.com\/mf\/web\/u2frav\/Covid_19_TomK_JillanneS_Advocacy_Strategies_4_27_2020_mixdown.mp3","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202211\/54de86-ba12-6041-f883ee_800.jpg"},"title":"COVID-19 Advocacy: Working with the Federal Agencies","link":"javascript:;","id":"item-1546389"}]
